Drug Type Biosimilar, Antibody fusion proteins |
Synonyms Romiplostim Biosimilar (Enzene Biosciences Ltd.), 罗米司亭生物类似药(Enzene Biosciences Ltd.), 267639-76-9 |
Target |
Mechanism TPO receptor agonists(Thrombopoietin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Purpura, Thrombocytopenic, Idiopathic | Phase 3 | - | - |